Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin-15 receptor quaternary complex is the molecular unit mediating IL-15 signaling. IL-15 first binds with high affinity to IL-15Rα (the alpha subunit), often in the *trans*-presentation mode by antigen-presenting or stromal cells. This complex then associates with the beta (IL-2Rβ) and common gamma (γc) receptor subunits present on responding lymphocytes (NK cells, CD8+ T cells), triggering intracellular signaling pathways (e.g., JAK/STAT, PI3K/AKT). This receptor assembly is essential for immune cell survival, proliferation, and function, and is a focus for therapeutic manipulation in cancer immunotherapy and infectious disease. The terminology in literature varies; the standard is to specify all subunits as IL-15–IL-15Rα–IL-2Rβ–γc.
Agonists: promote or mimic IL-15 binding and activation, resulting in immune cell proliferation, survival (often by *trans*-presentation). Antagonists: block any subunit or disrupt complex formation, reducing immune activation. Superagonist complexes: combine IL-15 with IL-15Rα to stabilize and amplify signaling.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-15 receptor quaternary complex (IL-15–IL-15Rα–IL-2Rβ–γc) (IL-15R quaternary complex).